Aptevo Therapeutics Stock Quote APVO - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.29

Bid

0.275

Ask

0.29

Volume

12,817,626

0.2243 Day's Range 0.3255

0.138 52 Week Range 10.80

Market Cap

5.369M

Previous Close

0.2499

Open

0.264

Last Trade

0.2899

Last Trade Time

Financial Volume

$ 3,488,404

VWAP

0.272157

Average Volume (3m)

6,961,648

Shares Outstanding

18,512,084

Dividend Yield

PE Ratio

-0.31

Earnings Per Share (EPS)

-0.94

Revenue

Net Profit

-17.41M

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aptevotherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

Aptevo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APVO. The last closing price for Aptevo Therapeutics was $0.25. Over the last year, Aptevo Therapeutics shares have traded in a share price range of $ 0.138 to $ 10.80.

Aptevo Therapeutics currently has 18,512,084 shares outstanding. The market capitalization of Aptevo Therapeutics is $4.63 million. Aptevo Therapeutics has a price to earnings ratio (PE ratio) of -0.31.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.025	9.43396226415	0.265	0.3	0.2022	1030188	0.23425109	CS
4	-0.03	-9.375	0.32	0.3533	0.2022	2985043	0.27896226	CS
12	-0.0877	-23.2194863648	0.3777	0.515	0.138	6961648	0.2840341	CS
26	-0.49	-62.8205128205	0.78	0.89	0.138	6073310	0.41337006	CS
52	-8.818	-96.8159859464	9.108	10.8	0.138	3418904	0.72645259	CS
156	-325.75	-99.9110538584	326.04	971.5156	0.138	1601277	136.06503123	CS
260	-26.5632	-98.9200542207	26.8532	2640	0.138	1143169	207.18777406	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FBRXForte Biosciences Inc	$ 13.60 (129.53%)	28.92M
QSIQuantum Si Inc	$ 1.39 (119.59%)	279.33M
XCURExicure Inc	$ 11.01 (89.18%)	22.91M
AGFYAgrify Corporation	$ 37.4635 (68.00%)	921.45k
SLXNSilexion Therapeutics Corporation	$ 0.3495 (54.51%)	198.66M
SKKSKK Holdings Limited	$ 4.55 (-47.28%)	816.93k
QMMMQMMM Holdings Limited	$ 0.713999 (-43.78%)	4.61M
XTKGX3 Holdings Company Ltd	$ 0.0901 (-37.82%)	5.95M
PRFXPainReform Ltd	$ 1.02 (-27.14%)	5.09M
GLEGlobal Engine Group Holding Ltd	$ 3.81 (-26.59%)	230.23k
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.191 (17.39%)	662.68M
DBGIDigital Brands Group Inc	$ 0.1345 (15.35%)	326.45M
NVDANVIDIA Corporation	$ 145.89 (-0.76%)	309.57M
QSIQuantum Si Inc	$ 1.39 (119.59%)	283.09M
SLXNSilexion Therapeutics Corporation	$ 0.3495 (54.51%)	200.06M